Literature DB >> 32190623

Study on the correlation and predictive value of serum pregnancy-associated plasma protein A, triglyceride and serum 25-hydroxyvitamin D levels with gestational diabetes mellitus.

Zhuo Ren1, Dong Zhe1, Zhi Li1, Xin-Ping Sun2, Kai Yang1, Li Lin3.   

Abstract

BACKGROUND: Gestational diabetes mellitus (GDM) is a concern due to its rapid increase in incidence in recent years. AIM: To investigate the correlation and predictive value of serum pregnancy-associated plasma protein A (PAPP-A), triglyceride (TG), and 25-hydroxyvitamin D [25-(OH)D] with GDM in early pregnancy.
METHODS: A total of 99 patients in early pregnancy admitted to Peking University International Hospital from November 2015 to September 2017 were included, and underwent a fasting glucose test and oral glucose tolerance test screening at 24-28 wk of pregnancy. Of these cases with GDM, 51 were assigned to group A and the remaining 48 cases without GDM were enrolled in group B. Serum PAPP-A, TG and 25-(OH)D in the two groups were compared and their correlation with blood sugar was analyzed. In addition, their diagnostic value in GDM was determined using receiver operating characteristic (ROC) curve analysis.
RESULTS: Group A had markedly lower serum PAPP-A and 25-(OH)D levels and a significantly higher serum TG level than group B, with statistical significance (P < 0.05). Furthermore, Pearson analysis identified that PAPP-A and 25-(OH)D levels were negatively correlated with fasting blood glucose (FBG) levels (r = -0.605, P < 0.001), (r = -0.597, P < 0.001), while TG and FBG levels were positively correlated (r = 0.628, P < 0.001). The sensitivity, specificity, area under the curve (AUC) and optimal cut-off value of serum PAPP-A level in the diagnosis of GDM were 72.55%, 82.35%, 0.861 and 16.340, respectively, while the sensitivity of TG in diagnosing GDM was 86.27%, the specificity was 66.67%, the AUC was 0.813, with an optimal cut-off value of 1.796. The corresponding sensitivity, specificity, AUC and optimal cut-off value of serum 25-(OH)D were 64.71%, 70.59%, 0.721 and 23.140, respectively. Moreover, multivariate logistic regression analysis revealed that FBG, vascular endothelial growth factor, Flt-1, serum PAPP-A, TG, and 25-(OH)D were related risk factors leading to GDM in patients.
CONCLUSION: Serum PAPP-A, TG, and 25-(OH)D levels are all correlated with blood glucose changes in GDM, and are independent factors affecting the occurrence of GDM and have certain value in the diagnosis of GDM. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Early pregnancy; Gestational diabetes mellitus; Oral glucose tolerance test; Serum 25-hydroxyvitamin D; Serum pregnancy-associated plasma protein A level; Triglyceride

Year:  2020        PMID: 32190623      PMCID: PMC7062615          DOI: 10.12998/wjcc.v8.i5.864

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  24 in total

1.  Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.

Authors:  Maryam Karamali; Shahla Bahramimoghadam; Fateme Sharifzadeh; Zatollah Asemi
Journal:  Appl Physiol Nutr Metab       Date:  2018-01-09       Impact factor: 2.665

2.  Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women.

Authors:  L Pietro; S Daher; M V C Rudge; I M P Calderon; D C Damasceno; Y K Sinzato; C Bandeira; E Bevilacqua
Journal:  Placenta       Date:  2010-08-01       Impact factor: 3.481

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.

Authors:  N Tul; K Spencer; P Noble; C Chan; K Nicolaides
Journal:  Prenat Diagn       Date:  1999-11       Impact factor: 3.050

Review 5.  First trimesters Pregnancy-Associated Plasma Protein-A levels value to Predict Gestational diabetes Mellitus: A systematic review and meta-analysis of the literature.

Authors:  Zahra Hadizadeh Talasaz; Ramin Sadeghi; Fariba Askari; Salmeh Dadgar; Atiyeh Vatanchi
Journal:  Taiwan J Obstet Gynecol       Date:  2018-04       Impact factor: 1.705

6.  Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case-control study.

Authors:  Elisabetta Lovati; Fausta Beneventi; Margherita Simonetta; Marco Laneri; Lara Quarleri; Luigia Scudeller; Giulia Albonico; Elena Locatelli; Chiara Cavagnoli; Carmine Tinelli; Arsenio Spinillo; Gino R Corazza
Journal:  Diabetes Res Clin Pract       Date:  2013-05-01       Impact factor: 5.602

7.  The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia.

Authors:  Eun Sung Lee; Min-Jeong Oh; Jae Won Jung; Ji-Eun Lim; Hyun-Joo Seol; Kyung-Ju Lee; Hai-Joong Kim
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

8.  A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.

Authors:  Dorijn F L Hertroijs; Arianne M J Elissen; Martijn C G J Brouwers; Nicolaas C Schaper; Sebastian Köhler; Mirela C Popa; Stylianos Asteriadis; Steven H Hendriks; Henk J Bilo; Dirk Ruwaard
Journal:  Diabetes Obes Metab       Date:  2017-11-24       Impact factor: 6.577

9.  The Impact of Vitamin D Supplementation on Post-Partum Glucose Tolerance and Insulin Resistance in Gestational Diabetes: A Randomized Controlled Trial.

Authors:  Majid Valizadeh; Zahra Piri; Farnaz Mohammadian; Koorosh Kamali; Hamid Reza Amir Moghadami
Journal:  Int J Endocrinol Metab       Date:  2016-04-16

10.  Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.

Authors:  Y E Smith; S Toomey; S Napoletano; G Kirwan; C Schadow; A J Chubb; J H Mikkelsen; C Oxvig; J H Harmey
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.